NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Auxilium Biotechnologies

Auxilium Biotechnologies

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://auxiliumbio.com/

Last Round

VC Round

Dec 11, 2025

Est. Valuation

$92.6M

Total Funding Raised

$7.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Auxilium Biotechnologies is a biotechnology company that develops implantable medical devices and bioprinting solutions for the treatment of traumatic nerve injuries and pioneers space-based biomanufacturing technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Space Technology, 3D Printing, Smart Manufacturing

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicinein-space manufacturing3D bioprintingspace manufacturingnerve regenerationmedical implantsbiofabricationmicrogravity researchorbital manufacturingbiotechspace biotechbiomanufacturingmedical deviceclinical-stage biotechspace economy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Auxilium Biotechnologies Comps

Public and private peers based on sector, stage, and business model.

Auxilium Biotechnologies comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Auxilium Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 11, 2025
GrantMar 15, 2023
Series AJan 17, 2020

Auxilium Biotechnologies Investors

Notable investors and investment history

Auxilium Biotechnologies investors
InvestorRounds
NIH RADxGrant
Innovation PartnershipsSeries A
CF VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 11, 2025

    $4M raised in a VC Round.

Auxilium Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Auxilium Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Auxilium Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range4
Year Founded2019
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.